A guide to when they start working, patient experiences, how long the benefits last — and what to know about Tezepelumab

Biologic treatments — like omalizumab, mepolizumab, benralizumab, dupilumab, and now tezepelumab — have transformed care for people with severe asthma and related lung conditions. But many patients naturally ask:

  • When will I start to feel better?

  • Will the benefit last?

  • Am I eligible for this treatment?

  • What if it wears off or I stop taking it?

  • Which biologic is right for me?


💷 Access to Biologics: Who Can Have Them?

Biologics are highly effective — but they are also expensive treatments, often costing £10,000–£30,000 per year. Because of this, the NHS only offers them to patients who meet strict criteria.

This helps ensure:

  • Fair access

  • Best use of NHS resources

  • That patients are likely to benefit

✅ To qualify for a biologic, patients must typically:

  1. Have confirmed severe asthma

    • Symptoms remain poorly controlled despite taking:

      • High-dose inhaled steroids (ICS)

      • Long-acting beta agonists (LABAs)

      • Other controller medication (e.g. montelukast)

  2. Have frequent asthma attacks

    • Usually 2 or more flare-ups in the past year needing:

      • Oral steroids (e.g. prednisolone)

      • A&E or hospital care

  3. Be using their inhalers properly and regularly

    • Doctors will check that medication is being taken as prescribed

    • Inhaler technique must be correct

    • Other problems (like reflux or anxiety) must be addressed first

  4. Have the right blood or allergy profile
    (This depends on which biologic is being considered):

Biologic Biomarker Criteria
Omalizumab IgE in range + allergic asthma
Mepolizumab/Benralizumab Eosinophils ≥150–300 cells/µL
Dupilumab Raised FeNO or IgE, plus eosinophilic features
Tezepelumab Works in a wider group, including low eosinophils
  1. Be assessed by a specialist team

    • Biologics are only prescribed after a full multidisciplinary review in a specialist asthma service

🔄 After Starting:

  • Patients are reviewed after 3–6 months

  • If there’s no improvement, treatment is stopped

  • Continued use depends on measurable benefit, such as:

    • Fewer attacks

    • Reduced steroid need

    • Better lung function or asthma control scores

💬 “Biologics are not a quick fix — but when matched carefully, they can be life-changing.”


⏳ When Will I Start Feeling Better?

Most patients begin to feel some improvement within the first few weeks to three months.

🟩 What Other Patients Say:

  • Lynn (USA):

    “Within five days, I could tell … I was not coughing as much.”

  • Mena, 17 (USA):

    “She doesn’t have to rely on steroids as much.”
    “Now I’m stable.”

  • Catherine, 88 (UK):

    “Since taking biologics, I’ve not had to call the office about breathing problems once.”

  • UK Patient Survey:

    “Biologic treatment stopped the disruption of family and social life.”
    “Energy and mental health improved by 3 months.”


📈 Typical Timeline of Benefits:

Time After Starting What You May Notice
1–2 weeks Less coughing, better sleep, reduced night symptoms
2–4 weeks Easier breathing, less tightness, more energy
1–3 months Fewer flare-ups, less need for oral steroids
3–6 months Improved walking, daily life, and lung test scores
12 months Full review of benefit — continued if effective

📆 How Long Do the Benefits Last?

If the biologic is working and you stay on treatment, the benefits can last for years:

  • Many patients remain stable for 1–5 years or more

  • Biologics are ongoing treatments — not cures, but long-term control

  • If stopped, some patients stay well for a time, while others relapse


💡 Spotlight on Tezepelumab (Tezspire)

Tezepelumab is a newer biologic that works differently from the others — it targets TSLP, an upstream trigger of inflammation. This makes it suitable for a broader range of asthma patients, including those without high eosinophils or obvious allergies.

🔹 How It Works:

  • Blocks TSLP (thymic stromal lymphopoietin) — a key driver of inflammation

  • Works across multiple asthma types (eosinophilic, allergic, non-allergic)

🔹 Dosing:

  • 210 mg injection every 4 weeks (subcutaneous)

🔹 Benefits (NAVIGATOR & DESTINATION trials):

  • Reduces asthma attacks by 56% regardless of eosinophil count or allergic status

  • Improvement often seen within 2–4 weeks, with continued benefit over 1–2 years

  • Long-term studies show sustained effectiveness and good safety

  • After stopping, inflammation gradually returns but may remain better than baseline for a while

🧠 Tezepelumab is especially promising for patients who haven’t responded well to other biologics, or who don’t fit into the eosinophilic or allergic categories.


✅ In Summary:

Question Typical Answer
When will I feel better? 2–12 weeks, sometimes faster
How long does it last? Months to years if treatment continues
What if I stop? Symptoms may return gradually
Who can get a biologic? Patients meeting NHS criteria, reviewed by specialists
Tezepelumab use? For broad asthma types, including low-eosinophil asthma
Path: Start » Treatment » 🫁 Biologics for Severe Asthma and Respiratory Conditions: What to Expect

Latest News posts